The change in NT-proBNP levels observed in that study afforded to distinguish Dobermans in Stage II or III of DCM from healthy counterparts and the dogs with high levels of the fragment presented poor prognosis compared with those with lower concentrations. This evidence concerns the gene NPPB and familial dilated cardiomyopathy.